enGene Therapeutics Inc (FRA:S0N0)
€ 1.43 -0.030 (-2.05%) Market Cap: 98.90 Mil Enterprise Value: -95.46 Mil PE Ratio: 0 PB Ratio: 0.44 GF Score: 19/100

enGene Holdings Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2026 / 01:00 PM GMT
Release Date Price: €5.9 (-14.49%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ENGN.OQ - enGene Holdings Inc
enGene Holdings Inc at Barclays Global Healthcare Conference
Mar 10, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
On the chair behind the scenes.

Pretty exciting time.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
For that, right, yeah, great, thanks, everyone.

My name's Edward Derott, senior biotech analyst at Barclays. My pleasure to have Egene, with us, this morning, CEO, Ron Cooper. Ron, maybe if you can just, give us an introduction of Engene for those that are less familiar with the story, and then we'd, take it from there.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot